Displaying items by tag: MichBio
GRAND RAPIDS — The $160 million federal contract to produce a COVID-19 vaccine when it’s ready elevates Grand River Aseptic Manufacturing Inc. into what Tom Ross calls the “big leagues.”
GRAND RAPIDS — Tetra Therapeutics Inc.’s sale to a Japanese pharmaceutical company provides a final pathway toward bringing to market potential new drugs to treat Alzheimer’s disease and a form of autism, as well as generates a handsome return for financial backers.
The lame-duck session of Congress offers the opportunity for advocates to finally convince lawmakers to repeal a federal tax on medical devices.
MATTAWAN — The proposed sale of MPI Research Inc. to Charles River Laboratories International Inc. for $800 million would end local ownership for a company that’s one of the largest employers in the greater Kalamazoo area.
GRAND RAPIDS — In the three years since Peter Jones moved from Los Angeles to Grand Rapids, he’s helped to more than double the amount of federal research funding that Van Andel Institute receives.
KALAMAZOO — A major expansion by Stryker Corp. could provide a welcome shot in the arm for Southwest Michigan’s life sciences sector.
While West Michigan may lack the depth of resources and talent that some regions of the country possess when it comes to the medical device industry, it may have one key advantage: the affordability of its contract manufacturing.
The availability of scientific and executive management talent and the access to later-stage investment capital remain major issues for Michigan’s life sciences industry.
The restoration of an angel tax credit in Michigan looks doubtful before the present legislative term expires at the end of the year.